secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTEGRA LIFESCIENCES HOLDINGS CORP (IART)
CIK:        0000917520
Form:       8-K
Filed at:   2023-12-20T23:59:59+00:00
Accession:  0000917520-23-000082
Event type: debt
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01
LLM model:  deepseek-v4-flash:cloud@v2

Integra LifeSciences extends A/R securitization facility maturity to Dec 2026
-----------------------------------------------------------------------------

- Amendment No. 5 extends the $150M A/R securitization facility maturity to December 15, 2026.
- Facility originally entered Dec 2018; parties include Integra Receivables, ILS Sales, PNC Bank, and Bank of Nova Scotia.
- Company's limited performance guaranty continues in accordance with its terms.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/917520/000091752023000082/0000917520-23-000082-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/917520/000091752023000082/iart-20231215.htm
  HTML page:      https://secwatch.observer/filing/0000917520-23-000082

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer